This announcement details the completion of the restructuring process for Iovate Health Sciences International Inc. and its subsidiaries. The Canadian court approved the restructuring plan on April 16, 2026, with the buyer, 1001542267 Ontario Inc., acquiring the shares. The restructuring will not affect the domestic operations of the parent company, which will continue to focus on its core edible oil business.
Summary generated by AI · Always verify with source document
Securities Code: 000639
Securities Abbreviation: ST Xiwang
Announcement Number: 2026-029
Xiwang Food Co., Ltd. Announcement on the Completion of Restructuring of Subsidiary Company
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.